Crossref
Remodeling of tumour microenvironment of pancreatic cancer: can agonistic anti-CD40 antibodies give a new direction?
Annals of Pancreatic Cancer · 2026-08 · 9 · 23-23
DOI: 10.21037/apc-26-0019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-08. Verfasst von Eric C. H. Lai und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lai, E. C. H., & Ung, A. K. Y. (2026). Remodeling of tumour microenvironment of pancreatic cancer: can agonistic anti-CD40 antibodies give a new direction?. Annals of Pancreatic Cancer, 9, 23-23. https://doi.org/10.21037/apc-26-0019
Vancouver
Lai ECH, Ung AKY. Remodeling of tumour microenvironment of pancreatic cancer: can agonistic anti-CD40 antibodies give a new direction?. Annals of Pancreatic Cancer. 2026;9:23-23. doi:10.21037/apc-26-0019
BibTeX
@article{Lai2026,
author = {Lai, Eric C. H. and Ung, Aidan K. Y.},
title = {Remodeling of tumour microenvironment of pancreatic cancer: can agonistic anti-CD40 antibodies give a new direction?},
journal = {Annals of Pancreatic Cancer},
year = {2026},
volume = {9},
pages = {23--23},
doi = {10.21037/apc-26-0019}
}
EUVIMED